Allozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M
Allozymes’ innovative approach to rapidly testing millions of bio-based chemical reactions has transcended being merely a valuable service to becoming the foundation of a unique and invaluable dataset. This dataset…